Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS).
NCT ID: NCT06149897
Last Updated: 2025-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
54 participants
INTERVENTIONAL
2023-11-10
2026-02-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Direct Current Stimulation and Cognitive Behavioural Programme on Post-stroke Fatigue
NCT06810817
Behavioral and Neural Correlates of Post-Stroke Fatigue
NCT06088914
tDCS for Neurological Disability Among Subacute Stroke Survivors to Improve Multiple Domains in Quality of Life
NCT06110169
Transcranial Direct Current Stimulation in Post-stroke Fatigue
NCT04634864
Transcranial Direct Current Stimulation (tDCS) in Chronic Stroke Recovery
NCT01014897
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
* Therapeutic education about post-stroke fatigue
* Sham stimulation with tDCS: Anode placed in F3 and cathode in O2, 20 minutes.
* Aerobic exercise measured with Borg scale (moderate intensity)
tDCS
Non invasive brain stimulation with sham and active comparators
Experimental group
* Therapeutic education about post-stroke fatigue
* Stimulation with tDCS: Anode placed in F3 and cathode in O2, intensity 2mA during 20 minutes.
* Aerobic exercise measured with Borg scale (moderate intensity)
tDCS
Non invasive brain stimulation with sham and active comparators
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tDCS
Non invasive brain stimulation with sham and active comparators
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to understand and execute simple instructions
* Over 18 years.
* Fatigue Scale of fatigue severity with a score greater than or equal to 24
Exclusion Criteria
* Patients with decompensated cardiorespiratory and/or psychiatric pathology.
* Comorbidity causing disproportionate fatigue, such as long-term COVID.
* Patients who are cancer survivors or who are undergoing cancer treatment.
* Patients with a history of epilepsy or who are taking antiepileptic medication.
* Patents with major depression.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Clinic of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Inés García Bouyssou
Physical therapist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clínic de Barcelona
Barcelona, Spain, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCB/2022/1193
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.